ACKNOWLEDGMENTS
Cancer
INFECTIOUS DISEASES, CROSS, CANCER
The authors thank Himabindu Gutha, PhD, of Novartis Healthcare Pvt Ltd, Hyderabad, India, for providing medical writing and editorial support for the manuscript. The authors thank the patients and their families, and investigators and staff at each participating study site: National Cancer Center Hospital East; Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital; Kobe University Hospital; Osaka University Hospital; Fujita Health University; Akita University Hospital; Kindai University Hospital; Aomori Prefectural Central Hospital; Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital; University of Yamanashi Hospital; Hokkaido University Hospital; Yokohama City University Medical Center; Kyushu University Hospital; Osaka City University Hospital. This study was sponsored by Novartis Pharma K.K.(Japan).